His primary areas of study are Kallikrein, Cancer, Cancer research, Pathology and Internal medicine. His research in Kallikrein intersects with topics in Molecular biology and Gene family. His Cancer research includes themes of Immunology and Bioinformatics.
His studies in Cancer research integrate themes in fields like Gene expression, Carcinogenesis, LNCaP, Kidney and PTEN. The Pathology study combines topics in areas such as Prostate, Tumor marker, Mammary gland, KLK5 and Prostate cancer. The various areas that he examines in his Internal medicine study include Endocrinology and Oncology.
His main research concerns Internal medicine, Cancer research, Oncology, Cancer and Kallikrein. His studies in Internal medicine integrate themes in fields like Endocrinology and Pathology. His Cancer research research is multidisciplinary, incorporating elements of Real-time polymerase chain reaction, Gene expression, Gene, microRNA and Colorectal cancer.
His Oncology research is multidisciplinary, incorporating perspectives in Stage, Proportional hazards model, Disease, Univariate analysis and Biomarker. His work deals with themes such as Chemotherapy and Bioinformatics, which intersect with Cancer. The concepts of his Kallikrein study are interwoven with issues in Proteases and KLK5.
The scientist’s investigation covers issues in Cancer research, Internal medicine, Oncology, microRNA and Gene. His research integrates issues of Cancer cell, Apoptosis, Real-time polymerase chain reaction, Colorectal cancer and Chronic lymphocytic leukemia in his study of Cancer research. His Oncology research includes themes of Bladder cancer, Chemotherapy, Proportional hazards model, Disease and Survival analysis.
The microRNA study combines topics in areas such as Cancer, Clinical significance, Renal cell carcinoma, Pathology and Biomarker. His biological study deals with issues like Metastasis, which deal with fields such as Clear cell renal cell carcinoma. His Breast cancer research incorporates elements of KLK6, Kallikrein and Prostate cancer.
Andreas Scorilas mostly deals with Cancer research, microRNA, Real-time polymerase chain reaction, Pathology and Internal medicine. His Cancer research research is multidisciplinary, relying on both Immunology, Peripheral blood mononuclear cell, Chronic lymphocytic leukemia and Carcinogenesis. His Real-time polymerase chain reaction study integrates concerns from other disciplines, such as Colorectal cancer and Clinical significance.
His Pathology study incorporates themes from Cell, Gene expression and Metastasis. Internal medicine and Oncology are frequently intertwined in his study. His Survival analysis study deals with Biomarker intersecting with Cancer, Cancer development, Heterogeneous group, Signal transduction and Biogenesis.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
BCL2 family of apoptosis-related genes: functions and clinical implications in cancer.
Hellinida Thomadaki;Andreas Scorilas.
Critical Reviews in Clinical Laboratory Sciences (2006)
Overexpression of matrix-metalloproteinase-9 in human breast cancer: a potential favourable indicator in node-negative patients.
A Scorilas;A Karameris;N Arnogiannaki;A Ardavanis.
British Journal of Cancer (2001)
Human Kallikrein 6 (hK6): A New Potential Serum Biomarker for Diagnosis and Prognosis of Ovarian Carcinoma
Eleftherios P Diamandis;Andreas Scorilas;Stefano Fracchioli;Marleen Van Gramberen.
Journal of Clinical Oncology (2003)
Genomic organization of the human kallikrein gene family on chromosome 19q13.3-q13.4.
George M. Yousef;George M. Yousef;Albert Chang;Albert Chang;Andreas Scorilas;Andreas Scorilas;Eleftherios P. Diamandis;Eleftherios P. Diamandis.
Biochemical and Biophysical Research Communications (2000)
The serum concentration of human kallikrein 10 represents a novel biomarker for ovarian cancer diagnosis and prognosis
Liu-Ying Luo;Dionyssios Katsaros;Andreas Scorilas;Stefano Fracchioli.
Cancer Research (2003)
The Role of BCL2 Family of Apoptosis Regulator Proteins in Acute and Chronic Leukemias
Flora Tzifi;Christina Economopoulou;Dimitrios Gourgiotis;Alexandros Ardavanis.
Advances in Hematology (2012)
Parallel Overexpression of Seven Kallikrein Genes in Ovarian Cancer
George M. Yousef;Mary-Ellen Polymeris;George M. Yacoub;Andreas Scorilas.
Cancer Research (2003)
Human kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancer.
H Kim;H Kim;A Scorilas;A Scorilas;D Katsaros;G M Yousef;G M Yousef.
British Journal of Cancer (2001)
Human kallikrein 5: a potential novel serum biomarker for breast and ovarian cancer.
George M. Yousef;Mary Ellen Polymeris;Linda Grass;Antoninus Soosaipillai.
Cancer Research (2003)
The miR-17-92 Cluster is Over Expressed in and Has an Oncogenic Effect on Renal Cell Carcinoma
Tsz-fung F. Chow;Marina Mankaruos;Andreas Scorilas;Youssef Youssef.
The Journal of Urology (2010)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Mount Sinai Hospital
University of Toronto
University of Turin
Technical University of Munich
Ludwig-Maximilians-Universität München
National and Kapodistrian University of Athens
University of Toronto
KU Leuven
University of Helsinki
Technical University of Munich
Arizona State University
Amazon (United States)
Georgia Institute of Technology
University of Sheffield
Imec
Columbia University
University of Michigan–Ann Arbor
Spanish National Research Council
University of North Carolina Wilmington
University of Essex
University Medical Center Groningen
Friedrich Schiller University Jena
Imperial College London
University of California, Riverside
Johns Hopkins University
University of Alabama at Birmingham